Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.

Asalla S, Mohareer K, Banerjee S.

Front Cell Infect Microbiol. 2017 Oct 10;7:439. doi: 10.3389/fcimb.2017.00439. eCollection 2017.

2.

Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.

Di Franco M, Lucchino B, Spaziante M, Iannuccelli C, Valesini G, Iaiani G.

Int J Mol Sci. 2017 Jan 29;18(2). pii: E293. doi: 10.3390/ijms18020293. Review.

3.

Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.

Rider P, Carmi Y, Cohen I.

Int J Cell Biol. 2016;2016:9259646. doi: 10.1155/2016/9259646. Epub 2016 Dec 19. Review.

4.

Cytokines and Chemokines in Mycobacterium tuberculosis Infection.

Domingo-Gonzalez R, Prince O, Cooper A, Khader SA.

Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.TBTB2-0018-2016. Review.

5.

Protein phosphatase, Mg2+/Mn2+-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection.

Sun J, Schaaf K, Duverger A, Wolschendorf F, Speer A, Wagner F, Niederweis M, Kutsch O.

Oncotarget. 2016 Mar 29;7(13):15394-409. doi: 10.18632/oncotarget.8190.

6.

Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.

Ravimohan S, Tamuhla N, Nfanyana K, Steenhoff AP, Letlhogile R, Frank I, MacGregor RR, Gross R, Weissman D, Bisson GP.

Clin Infect Dis. 2016 Mar 15;62(6):795-803. doi: 10.1093/cid/civ978. Epub 2015 Nov 26.

7.

New insights into TB physiology suggest untapped therapeutic opportunities.

Baer CE, Rubin EJ, Sassetti CM.

Immunol Rev. 2015 Mar;264(1):327-43. doi: 10.1111/imr.12267. Review.

8.

Cytokine and lipid mediator networks in tuberculosis.

Mayer-Barber KD, Sher A.

Immunol Rev. 2015 Mar;264(1):264-75. doi: 10.1111/imr.12249. Review.

9.

Immunology studies in non-human primate models of tuberculosis.

Flynn JL, Gideon HP, Mattila JT, Lin PL.

Immunol Rev. 2015 Mar;264(1):60-73. doi: 10.1111/imr.12258. Review.

10.

Onion peel water extracts enhance immune status in forced swimming rat model.

Lee HA, Han SJ, Hong S, Kim DW, Oh GW, Kim O.

Lab Anim Res. 2014 Dec;30(4):161-8. doi: 10.5625/lar.2014.30.4.161. Epub 2014 Dec 24.

11.

Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization.

Gideon HP, Phuah J, Myers AJ, Bryson BD, Rodgers MA, Coleman MT, Maiello P, Rutledge T, Marino S, Fortune SM, Kirschner DE, Lin PL, Flynn JL.

PLoS Pathog. 2015 Jan 22;11(1):e1004603. doi: 10.1371/journal.ppat.1004603. eCollection 2015 Jan.

12.

Genetic recapitulation of human pre-eclampsia risk during convergent evolution of reduced placental invasiveness in eutherian mammals.

Elliot MG, Crespi BJ.

Philos Trans R Soc Lond B Biol Sci. 2015 Mar 5;370(1663):20140069. doi: 10.1098/rstb.2014.0069.

13.

Tuneable resolution as a systems biology approach for multi-scale, multi-compartment computational models.

Kirschner DE, Hunt CA, Marino S, Fallahi-Sichani M, Linderman JJ.

Wiley Interdiscip Rev Syst Biol Med. 2014 Jul-Aug;6(4):289-309. doi: 10.1002/wsbm.1270. Epub 2014 May 9. Review.

14.

Discordance in CD4+T-cell levels and viral loads with co-occurrence of elevated peripheral TNF-α and IL-4 in newly diagnosed HIV-TB co-infected cases.

Benjamin R, Banerjee A, Sunder SR, Gaddam S, Valluri VL, Banerjee S.

PLoS One. 2013 Aug 1;8(8):e70250. doi: 10.1371/journal.pone.0070250. Print 2013.

15.

Immunostimulating effects of extract of Acanthopanax sessiliflorus.

Kim JH, Shin EH, Lee HY, Lee BG, Park SH, Moon DI, Goo GC, Kwon DY, Yang HJ, Kim OJ, Oh HG.

Exp Anim. 2013;62(3):247-53.

16.

Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor.

Chung KB, Lee EY, Im JP, Han SK, Yim JJ.

Korean J Intern Med. 2013 Mar;28(2):174-9. doi: 10.3904/kjim.2013.28.2.174. Epub 2013 Feb 27.

17.

Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model.

Mueller AK, Behrends J, Hagens K, Mahlo J, Schaible UE, Schneider BE.

PLoS One. 2012;7(10):e48110. doi: 10.1371/journal.pone.0048110. Epub 2012 Oct 26.

18.

NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis.

Fallahi-Sichani M, Kirschner DE, Linderman JJ.

Front Physiol. 2012 Jun 6;3:170. doi: 10.3389/fphys.2012.00170. eCollection 2012.

19.

Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.

Subbian S, Tsenova L, O'Brien P, Yang G, Koo MS, Peixoto B, Fallows D, Dartois V, Muller G, Kaplan G.

PLoS Pathog. 2011 Sep;7(9):e1002262. doi: 10.1371/journal.ppat.1002262. Epub 2011 Sep 15.

20.

Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.

Subbian S, Tsenova L, O'Brien P, Yang G, Koo MS, Peixoto B, Fallows D, Zeldis JB, Muller G, Kaplan G.

Am J Pathol. 2011 Jul;179(1):289-301. doi: 10.1016/j.ajpath.2011.03.039. Epub 2011 May 7.

Supplemental Content

Support Center